Results 211 to 220 of about 15,131 (222)

Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy

Nature Nanotechnology, 2019
Zhuxian Zhou, Qingsong Yu, Jianbin Tang
exaly  

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Lancet, The, 2004
Caroline L Trotter, Mary Elizabeth Ramsay   +1 more
exaly  

Targeted Delivery of Oligonucleotide–Peptide Conjugates for Enhanced Kidney-Specific Therapy

Journal of Medicinal Chemistry
Morgane Mannes, Dora Mugoli Chigoho, Charlotte Martin, Thomas Barlow, Tine Hectors, Tom Govaerts, Pieterjan Kayaert, Kirsten De Ridder, Carole Delachaume, Béatrice Vayssière, Martin Andrews, Sophie Hernot, Steven Ballet   +12 more
openaire   +1 more source

Strategies and challenges for the next generation of antibody–drug conjugates

Nature Reviews Drug Discovery, 2017
Alain Beck, Charles Marie Dumontet
exaly  

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination

Lancet, The, 2002
Martin C J Maiden
exaly  

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

Lancet, The, 2003
Katherine O'Brien, Lawrence H Moulton, Raymond Reid   +2 more
exaly  

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

Lancet, The, 2005
Paul Jm Milligan
exaly  

Small conjugate-based theranostic agents: an encouraging approach for cancer therapy

Chemical Society Reviews, 2015
Rajesh Kumar, Kyoung Sunwoo, Seyoung Koo
exaly  

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

Lancet, The, 2005
exaly  

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

Lancet, The, 2014
exaly